Radiopharmaceuticals Market Size 2024 to 2031

The prevalence of cancer is increasing at the global level. For instance, according to the Global Cancer Observatory, approximately 19,292,789 new cases of cancer were detected worldwide in 2020. Among these, 10,065,305 new cases were diagnosed in the global male population. Also, the most common Product Types of cancer diagnosed in males in 2020 were lung cancer accounting for 14.3% of the total cases, followed by prostate cancer at 14.1%, colorectal cancer at 10.6%, and stomach cancer at 7.1% of the total cases respectively. Thus, the increasing prevalence of cancer is accelerating the demand for radiopharmaceuticals to administrate intravenously to be delivered to a target tumor. This prime factor is accelerating market growth.

ID : IL_612 | Language's : En/Jp/Fr/De | Publisher : IL | Format :